Labrys Biologics

Labrys Biologics was a clinical-stage biopharmaceutical company founded in 2012 and headquartered in San Mateo, California, developing monoclonal antibody therapeutics targeting calcitonin gene-related peptide (CGRP) for the prevention of chronic and episodic migraine. The company was venture-backed, with Canaan Partners among its investors, and was acquired by Teva Pharmaceutical Industries in 2014, after which its lead anti-CGRP antibody program continued under Teva. Labrys Biologics no longer operates as an independent company and maintains no developer or API surface: enrichment probes on 2026-07-19 found the registrant domain labrysbiologics.com resolving but serving nothing (TCP 80 and 443 closed), delegated to Teva nameservers, with a no-mail SPF/DMARC lockdown and no GitHub organization. This profile is retained as a historical portfolio-company record rather than an API listing.

Labrys Biologics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Therapeutics.

🌐 Visit website 📡 Source on GitHub

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPharmaceuticalsLife SciencesTherapeuticsNeurologyClinical ResearchAcquired

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 7.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/labrys-biologics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Source (apis.yml)

aid: labrys-biologics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/labrys-biologics.png
name: Labrys Biologics
description: 'Labrys Biologics was a clinical-stage biopharmaceutical company founded in 2012 and headquartered in San Mateo,
  California, developing monoclonal antibody therapeutics targeting calcitonin gene-related peptide (CGRP) for the prevention
  of chronic and episodic migraine. The company was venture-backed, with Canaan Partners among its investors, and was acquired
  by Teva Pharmaceutical Industries in 2014, after which its lead anti-CGRP antibody program continued under Teva. Labrys
  Biologics no longer operates as an independent company and maintains no developer or API surface: enrichment probes on 2026-07-19
  found the registrant domain labrysbiologics.com resolving but serving nothing (TCP 80 and 443 closed), delegated to Teva
  nameservers, with a no-mail SPF/DMARC lockdown and no GitHub organization. This profile is retained as a historical portfolio-company
  record rather than an API listing.'
url: https://raw.githubusercontent.com/api-evangelist/labrys-biologics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-status: acquired
x-acquired-by: teva
x-acquired-year: 2014
x-operating: false
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Therapeutics
- Neurology
- Clinical Research
- Acquired
apis: []
common:
- type: DomainSecurity
  url: security/labrys-biologics-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Labrys Biologics

Kin Score

Security Posture 1

Labrys Biologics Domain Security

Resources

Access & Security 1

Source (apis.yml)